View All Key Stats
LLY Key Stats
| Income Statement | |
| Revenue (TTM) | 23.34B |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | 1.07 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | 1.124B |
| Profitability | |
| Gross Profit Margin (Quarterly) | 72.43% |
| Profit Margin (Quarterly) | 21.36% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | Upgrade |
| Price and Valuation | |
| Market Cap | 93.26B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 3.871 |
| PE Ratio (TTM) | 80.30 |
| Price to Book Value | 6.420 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | Upgrade |
| Free Cash Flow (Quarterly) | 200.00M |
| Return on Equity (TTM) | Upgrade |
View All LLY News
LLY News
-
WireHeadlineTime (ET)
-
PR Newswire06/23 10:00
-
PR Newswire06/23 10:00
-
PR Newswire06/23 08:00
-
SA Breaking News06/22 18:35
-
MT Newswires06/22 16:01
-
PR Newswire06/22 15:49
-
MT Newswires06/22 08:46
-
PR Newswire06/22 08:31
-
MT Newswires06/18 17:41
-
MT Newswires06/18 16:38
View All Events
LLY Events
| Date | Type | Description |
|---|---|---|
| 08/14/2018 | Dividends | Amount: 0.5625, Declared Date: Jun 18 2018, Pay Date: Sep 10 2018 |
| 07/25/2018 | Misc | Eli Lilly and Co Second Quarter Earnings Conference Call in 2018 |
| 07/25/2018 | Earnings | Eli Lilly and Co Second Quarter Earnings Results in 2018 |
| 05/16/2018 | Dividends | Amount: 0.5625, Declared Date: May 08 2018, Pay Date: Jun 08 2018 |
| 05/07/2018 | Misc | Eli Lilly and Co Annual General Meeting in 2017 |
| 04/24/2018 09:00 EDT | Misc | Eli Lilly and Co First Quarter Earnings Conference Call in 2018 |
| 04/24/2018 | Earnings | Eli Lilly and Co First Quarter Earnings Results in 2018 |
| 02/14/2018 | Dividends | Amount: 0.5625, Declared Date: Dec 11 2017, Pay Date: Mar 09 2018 |
| 01/31/2018 09:00 EST | Misc | Eli Lilly and Co Fourth Quarter Earnings Conference Call in 2017 |
| 01/31/2018 | Earnings | Eli Lilly and Co Fourth Quarter Earnings Results in 2017 |
LLY Fundamentals
Income Statement View Statement
LLY Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
LLY One Page Reports
- One Page Report Download
LLY Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Consensus Rating | Upgrade |
| Target Price | |
| Price | 85.92 |
| Price Target | Upgrade |
| Price Target Upside (Daily) | Upgrade |
Edit
Profile
- URL: http://www.lilly.com
- Investor Relations URL: https://investor.lilly.com/
- HQ State/Province: Indiana
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Large Cap/Blend
- Next Earnings Release: Jul. 25, 2018
- Last Earnings Release: Apr. 24, 2018
- Next Ex-Dividend Date: Aug. 14, 2018
- Last Ex-Dividend Date: May. 16, 2018
- Description: Eli Lilly and Co is a pharmaceutical company with a focus on neuroscience, endocrinology, oncology, and immunology. It discovers, develops, manufactures, and sells human pharmaceutical products and animal health products.
LLY Excel Add-In Codes
- Name: =YCI("LLY","name")
- Description: =YCI("LLY","description")
- Sector: =YCI("LLY","sector")
- Industry: =YCI("LLY","industry")
- Est. Current Fiscal Year End: =YCI("LLY","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other LLY Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- LLY Tweets Stocktwits
Advertisement
